Randomized controlled trialHumanClinical Trial, Phase III
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity
The New England journal of medicine, 2024 Oct 3. Malhotra A, Grunstein RR, Fietze I and 10 others.
Study type
Randomized controlled trial · Clinical Trial, Phase III
Subjects
Human participants (PubMed MeSH: Humans)
Journal
The New England journal of medicine
Published
2024 Oct 3
PubMed
Where PepCue cites this
This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.
Indexed under
MeSH terms assigned by the National Library of Medicine.
AdultFemaleHumansMaleMiddle AgedBlood PressureBody WeightC-Reactive ProteinDouble-Blind MethodHypoxiaObesitySleep Apnea, Obstructive
Other papers on Tirzepatide
Randomized controlled trial · 2022
Tirzepatide Once Weekly for the Treatment of Obesity
Randomized controlled trial · 2021Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page